Is KPRX or KPTI more undervalued in 2026?

CirclFi compares Kiora Pharmaceuticals, Inc. (KPRX) and Karyopharm Therapeutics Inc. (KPTI) using 13 institutional-grade valuation models. KPRX has a Quality of Company score of 5.5/10 while KPTI scores 5.1/10.

Which is a better buy — KPRX or KPTI?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do KPRX and KPTI valuations compare?

KPRX at $2.68 and KPTI at $9.10 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

KPRX vs KPTI Valuation Comparison 2026 — Intrinsic Value Analysis

KPRX

Pharmaceutical Preparations

Kiora Pharmaceuticals, Inc.

Quality

5.5

out of 10

Value Trap

LOW

Price

$2.68

Last close

Models

8/13

Active

KPTI

Pharmaceutical Preparations

Karyopharm Therapeutics Inc.

Quality

5.1

out of 10

Value Trap

LOW

Price

$9.10

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	KPRX Fair Value	KPRX Upside	KPTI Fair Value	KPTI Upside
Bayesian DCF	Intrinsic	$2.01	-24.8%	$3.13	-65.6%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.48	-80.2%	$9.83	+8.0%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$3.98	+48.7%	$23.88	+162.4%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for KPRX vs KPTI — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

KPRX vs KPTI — Which Stock Is More Undervalued?

KPRX scores higher with a 5.5/10 quality rating vs KPTI's 5.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Kiora Pharmaceuticals, Inc. (KPRX) and Karyopharm Therapeutics Inc. (KPTI) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

KPRX currently trades at $2.68 with a QOC of 5.5/10, while KPTI trades at $9.10 with a QOC of 5.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).